Table of Contents

June 2009, Volume 16, Number 2

Commentary

    • Qun Zhou,
    • Patrick G Shaw,
    • and Nancy E Davidson

    Epigenetics meets estrogen receptor: regulation of estrogen receptor by direct lysine methylation

    Endocr Relat Cancer 16 (2) 319-323, doi:10.1677/ERC-08-0305 first published on 10 February 2009

Review

    • Jason M D'Antonio,
    • Donald J Vander Griend,
    • and John T Isaacs

    DNA licensing as a novel androgen receptor mediated therapeutic target for prostate cancer

    Endocr Relat Cancer 16 (2) 325-332, doi:10.1677/ERC-08-0205 first published on 24 February 2009
    • Claudia Lanari,
    • Caroline A Lamb,
    • Victoria T Fabris,
    • Luisa A Helguero,
    • Rocío Soldati,
    • María Cecilia Bottino,
    • Sebastián Giulianelli,
    • Juan Pablo Cerliani,
    • Victoria Wargon,
    • and Alfredo Molinolo

    The MPA mouse breast cancer model: evidence for a role of progesterone receptors in breast cancer

    Endocr Relat Cancer 16 (2) 333-350, doi:10.1677/ERC-08-0244 first published on 3 February 2009
    • Gwen E Dressing,
    • Christy R Hagan,
    • Todd P Knutson,
    • Andrea R Daniel,
    • and Carol A Lange

    Progesterone receptors act as sensors for mitogenic protein kinases in breast cancer models

    Endocr Relat Cancer 16 (2) 351-361, doi:10.1677/ERC-08-0281 first published on 8 April 2009
    • Parvesh Chaudhry and
    • Eric Asselin

    Resistance to chemotherapy and hormone therapy in endometrial cancer

    Endocr Relat Cancer 16 (2) 363-380, doi:10.1677/ERC-08-0266 first published on 3 February 2009
    • Mathieu Lupien and
    • Myles Brown

    Cistromics of hormone-dependent cancer

    Endocr Relat Cancer 16 (2) 381-389, doi:10.1677/ERC-09-0038 first published on 15 April 2009
    • Henri J L M Timmers,
    • Anne-Paule Gimenez-Roqueplo,
    • Massimo Mannelli,
    • and Karel Pacak

    Clinical aspects of SDHx-related pheochromocytoma and paraganglioma

    Endocr Relat Cancer 16 (2) 391-400, doi:10.1677/ERC-08-0284 first published on 3 February 2009

Regular papers

    • Claudio Festuccia,
    • Giovanni Luca Gravina,
    • Anna Maria D'Alessandro,
    • Paola Muzi,
    • Danilo Millimaggi,
    • Vincenza Dolo,
    • Enrico Ricevuto,
    • Carlo Vicentini,
    • and Mauro Bologna

    Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models

    Endocr Relat Cancer 16 (2) 401-413, doi:10.1677/ERC-08-0130 first published on 19 January 2009
    • Kenichiro Ishii,
    • Tetsuya Imamura,
    • Kazuhiro Iguchi,
    • Shigeki Arase,
    • Yuko Yoshio,
    • Kiminobu Arima,
    • Kazuyuki Hirano,
    • and Yoshiki Sugimura

    Evidence that androgen-independent stromal growth factor signals promote androgen-insensitive prostate cancer cell growth in vivo

    Endocr Relat Cancer 16 (2) 415-428, doi:10.1677/ERC-08-0219 first published on 17 March 2009
    • Ashish Shukla,
    • Jean Grisouard,
    • Volker Ehemann,
    • Alexander Hermani,
    • Harald Enzmann,
    • and Doris Mayer

    Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines

    Endocr Relat Cancer 16 (2) 429-441, doi:10.1677/ERC-08-0240 first published on 19 January 2009
    • Marina Bagnoli,
    • Federico Ambrogi,
    • Silvana Pilotti,
    • Paola Alberti,
    • Antonino Ditto,
    • Mattia Barbareschi,
    • Enzo Galligioni,
    • Elia Biganzoli,
    • Silvana Canevari,
    • and Delia Mezzanzanica

    c-FLIPL expression defines two ovarian cancer patient subsets and is a prognostic factor of adverse outcome

    Endocr Relat Cancer 16 (2) 443-453, doi:10.1677/ERC-08-0218 first published on 25 March 2009
    • Sonia Cheng,
    • Wei Liu,
    • Moises Mercado,
    • Shereen Ezzat,
    • and Sylvia L Asa

    Expression of the melanoma-associated antigen is associated with progression of human thyroid cancer

    Endocr Relat Cancer 16 (2) 455-466, doi:10.1677/ERC-09-0002 first published on 4 March 2009
    • Stéphanie Durand,
    • Carole Ferraro-Peyret,
    • Mireille Joufre,
    • Annie Chave,
    • Françoise Borson-Chazot,
    • Samia Selmi-Ruby,
    • and Bernard Rousset

    Molecular characteristics of papillary thyroid carcinomas without BRAF mutation or RET/PTC rearrangement: relationship with clinico-pathological features

    Endocr Relat Cancer 16 (2) 467-481, doi:10.1677/ERC-08-0081 first published on 10 February 2009
    • Monica Fedele,
    • Dario Palmieri,
    • Gennaro Chiappetta,
    • Rosa Pasquinelli,
    • Ivana De Martino,
    • Claudio Arra,
    • Giuseppe Palma,
    • Teresa Valentino,
    • Giovanna M Pierantoni,
    • Giuseppe Viglietto,
    • Jay L Rothstein,
    • Massimo Santoro,
    • and Alfredo Fusco

    Impairment of the p27kip1 function enhances thyroid carcinogenesis in TRK-T1 transgenic mice

    Endocr Relat Cancer 16 (2) 483-490, doi:10.1677/ERC-08-0272 first published on 4 March 2009
    • Natallia M Akulevich,
    • Vladimir A Saenko,
    • Tatiana I Rogounovitch,
    • Valentina M Drozd,
    • Eugeny F Lushnikov,
    • Victor K Ivanov,
    • Norisato Mitsutake,
    • Ryo Kominami,
    • and Shunichi Yamashita

    Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma

    Endocr Relat Cancer 16 (2) 491-503, doi:10.1677/ERC-08-0336 first published on 13 March 2009
    • Francien H van Nederveen,
    • Esther Korpershoek,
    • Ronald J deLeeuw,
    • Albert A Verhofstad,
    • Jacques W Lenders,
    • Winand N M Dinjens,
    • Wan L Lam,
    • and Ronald R de Krijger

    Array-comparative genomic hybridization in sporadic benign pheochromocytomas

    Endocr Relat Cancer 16 (2) 505-513, doi:10.1677/ERC-08-0241 first published on 19 January 2009
    • Umasuthan Srirangalingam,
    • Bernard Khoo,
    • Lisa Walker,
    • Fiona MacDonald,
    • Robert H Skelly,
    • Emad George,
    • David Spooner,
    • Linda B Johnston,
    • John P Monson,
    • Ashley B Grossman,
    • W M Drake,
    • Scott A Akker,
    • Patrick J Pollard,
    • Nick Plowman,
    • Norbert Avril,
    • Daniel M Berney,
    • Jacky M Burrin,
    • Rodney H Reznek,
    • V K Ajith Kumar,
    • Eamonn R Maher,
    • and Shern L Chew

    Contrasting clinical manifestations of SDHB and VHL associated chromaffin tumours

    Endocr Relat Cancer 16 (2) 515-525, doi:10.1677/ERC-08-0239 first published on 10 February 2009
    • B Havekes,
    • A A van der Klaauw,
    • M M Weiss,
    • J C Jansen,
    • A G L van der Mey,
    • A H J T Vriends,
    • B A Bonsing,
    • J A Romijn,
    • and E P M Corssmit

    Pheochromocytomas and extra-adrenal paragangliomas detected by screening in patients with SDHD-associated head-and-neck paragangliomas

    Endocr Relat Cancer 16 (2) 527-536, doi:10.1677/ERC-09-0024 first published on 16 March 2009
    • K Revill,
    • K J Dudley,
    • R N Clayton,
    • A M McNicol,
    • and W E Farrell

    Loss of neuronatin expression is associated with promoter hypermethylation in pituitary adenoma

    Endocr Relat Cancer 16 (2) 537-548, doi:10.1677/ERC-09-0008 first published on 13 February 2009
    • Susanna Vuorenoja,
    • Bidut Prava Mohanty,
    • Johanna Arola,
    • Ilpo Huhtaniemi,
    • Jorma Toppari,
    • and Nafis A Rahman

    Hecate-CGβ conjugate and gonadotropin suppression shows two distinct mechanisms of action in the treatment of adrenocortical tumors in transgenic mice expressing Simian Virus 40 T antigen under inhibin-α promoter

    Endocr Relat Cancer 16 (2) 549-564, doi:10.1677/ERC-08-0232 first published on 4 March 2009
    • Vassiliki Kotoula,
    • Elias Sozopoulos,
    • Helen Litsiou,
    • Galinos Fanourakis,
    • Triantafyllia Koletsa,
    • Gerassimos Voutsinas,
    • Sophia Tseleni-Balafouta,
    • Constantine S Mitsiades,
    • Axel Wellmann,
    • and Nicholas Mitsiades

    Mutational analysis of the BRAF, RAS and EGFR genes in human adrenocortical carcinomas

    Endocr Relat Cancer 16 (2) 565-572, doi:10.1677/ERC-08-0101 first published on 3 February 2009
    • P S H Soon,
    • A J Gill,
    • D E Benn,
    • A Clarkson,
    • B G Robinson,
    • K L McDonald,
    • and S B Sidhu

    Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas

    Endocr Relat Cancer 16 (2) 573-583, doi:10.1677/ERC-08-0237 first published on 13 February 2009
    • Cosimo Durante,
    • Houda Boukheris,
    • Clarisse Dromain,
    • Pierre Duvillard,
    • Sophie Leboulleux,
    • Dominique Elias,
    • Thierry de Baere,
    • David Malka,
    • Jean Lumbroso,
    • Joël Guigay,
    • Martin Schlumberger,
    • Michel Ducreux,
    • and Eric Baudin

    Prognostic factors influencing survival from metastatic (stage IV) gastroenteropancreatic well-differentiated endocrine carcinoma

    Endocr Relat Cancer 16 (2) 585-597, doi:10.1677/ERC-08-0301 first published on 24 February 2009
    • Carlos J P Álvarez,
    • María Lodeiro,
    • Marily Theodoropoulou,
    • Jesús P Camiña,
    • Felipe F Casanueva,
    • and Yolanda Pazos

    Obestatin stimulates Akt signalling in gastric cancer cells through β-arrestin-mediated epidermal growth factor receptor transactivation

    Endocr Relat Cancer 16 (2) 599-611, doi:10.1677/ERC-08-0192 first published on 19 January 2009
    • Volker Fendrich,
    • Ricarda Ramerth,
    • Jens Waldmann,
    • Katja Maschuw,
    • Peter Langer,
    • Detlef K Bartsch,
    • Emily P Slater,
    • Annette Ramaswamy,
    • and Matthias Rothmund

    Sonic hedgehog and pancreatic-duodenal homeobox 1 expression distinguish between duodenal and pancreatic gastrinomas

    Endocr Relat Cancer 16 (2) 613-622, doi:10.1677/ERC-08-0204 first published on 24 February 2009
    • Achim Fleischmann,
    • Beatrice Waser,
    • and Jean Claude Reubi

    High expression of gastrin-releasing peptide receptors in the vascular bed of urinary tract cancers: promising candidates for vascular targeting applications

    Endocr Relat Cancer 16 (2) 623-633, doi:10.1677/ERC-08-0316
    • Gail E de Blaquière,
    • Felicity E B May,
    • and Bruce R Westley

    Increased expression of both insulin receptor substrates 1 and 2 confers increased sensitivity to IGF-1 stimulated cell migration

    Endocr Relat Cancer 16 (2) 635-647, doi:10.1677/ERC-08-0216 first published on 4 March 2009
    • Jun-ichiro Suzuki,
    • Yasuko Murakami,
    • Keijiro Samejima,
    • Kohfuku Kohda Masahiro Ohtani,
    • and Takami Oka

    Antizyme is necessary for conversion of pancreatic tumor cells into glucagon-producing differentiated cells

    Endocr Relat Cancer 16 (2) 649-659, doi:10.1677/ERC-09-0004 first published on 6 April 2009

Erratum

|

This Issue

June 2009; 16 (2)
  1. Commentary
  2. Review
  3. Regular papers
  4. Erratum

Find articles in this issue containing these words:

New Articles: issue in progress

  1. April 2013, 20 (2)
  1. Current Issue
  1. Alert me to new issues of Endocrine-Related Cancer

Most